featured
Treatment Options for T2D Patients After Exenatide Twice Daily or Glimepiride + Metformin
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Treatment Escalation Options for Patients With Type 2 Diabetes After Failure of Exenatide BID or Glimepiride Added to Metformin: Results From the Prospective European Exenatide (EUREXA) Study
Diabetes Obes Metab 2015 Apr 01;[EPub Ahead of Print], G Schernthaner, J Rosas-Guzmán, F Dotta, B Guerci, R Simó, A Festa, J Kiljański, M Zhou, B GallwitzFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.